Genetic Susceptibility to Kidney Cancer
Stopped early
Conditions studied: Renal Cell Carcinoma
In brief
This study will further the understanding of the genetic events leading to the development of RCC.
Key facts
- Study ID
- NCT00854022
- Run by
- Baylor College of Medicine
- People needed
- 6
- Starts
- 2008-07-01
- Expected to finish
- 2013-03-01
- Last updated by the study team
- 2020-02-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year.
You may not qualify if…
- Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will
- Must not have had RCC, or metastatic RCC,
- Must not have had a renal transplantation
Where it is running
- MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.